These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24443270)

  • 1. Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma.
    Ebrahimi Shahmabadi H; Movahedi F; Koohi Moftakhari Esfahani M; Alavi SE; Eslamifar A; Mohammadi Anaraki G; Akbarzadeh A
    Tumour Biol; 2014 May; 35(5):4799-806. PubMed ID: 24443270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Cisplatin-loaded poly butyl cyanoacrylate nanoparticles on the ovarian cancer: an in vitro study.
    Bagherpour Doun SK; Alavi SE; Koohi Moftakhari Esfahani M; Ebrahimi Shahmabadi H; Alavi F; Hamzei S
    Tumour Biol; 2014 Aug; 35(8):7491-7. PubMed ID: 24789433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin.
    Ashrafzadeh MS; Akbarzadeh A; Heydarinasab A; Ardjmand M
    Int J Nanomedicine; 2020; 15():7035-7049. PubMed ID: 33061366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of 10-hydroxycamptothecin-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization.
    Jin X; Asghar S; Zhu X; Chen Z; Tian C; Yin L; Ping Q; Xiao Y
    Colloids Surf B Biointerfaces; 2018 Feb; 162():25-34. PubMed ID: 29145001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved Properties as an Anticancer Agent.
    Alavi SE; Muflih Al Harthi S; Ebrahimi Shahmabadi H; Akbarzadeh A
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, intestinal segment stability, and mucoadhesion properties of novel thymopentin-loaded chitosan derivatives coated with poly (n-butyl) cyanoacrylate nanoparticles.
    Xu Y; Lu S; Liu Q; Hong Y; Xu B; Ping Q; Jin X; Shen Y; Webster TJ; Rao Y
    Int J Nanomedicine; 2019; 14():1659-1668. PubMed ID: 30880971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model.
    Ambruosi A; Gelperina S; Khalansky A; Tanski S; Theisen A; Kreuter J
    J Microencapsul; 2006 Aug; 23(5):582-92. PubMed ID: 16980278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats.
    Ambruosi A; Khalansky AS; Yamamoto H; Gelperina SE; Begley DJ; Kreuter J
    J Drug Target; 2006 Feb; 14(2):97-105. PubMed ID: 16608736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
    Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine.
    Girotra P; Singh SK
    Pharm Res; 2016 Jul; 33(7):1682-95. PubMed ID: 27003706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, Characterization, and Evaluation of Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved In Vitro and In Vivo Anticancer Activities.
    Ghaferi M; Amari S; Mohrir BV; Raza A; Shahmabadi HE; Alavi SE
    Pharmaceuticals (Basel); 2020 Mar; 13(3):. PubMed ID: 32168743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies.
    Dhami NK; Pandey RS; Jain UK; Chandra R; Madan J
    J Microencapsul; 2014; 31(7):685-93. PubMed ID: 24963955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma.
    Gelperina SE; Khalansky AS; Skidan IN; Smirnova ZS; Bobruskin AI; Severin SE; Turowski B; Zanella FE; Kreuter J
    Toxicol Lett; 2002 Jan; 126(2):131-41. PubMed ID: 11751017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer Effect of Cisplatin-Loaded Poly (Butylcyanoacrylate) Nanoparticles on A172 Brain Cancer Cells Line.
    Chiani M; Toofani Milani A; Nemati M; Rezaeidian J; Ehsanbakhsh H; Ahmadi Z; Mazloomi E; Sadeghi V; Akbarzadeh Khiyavi A
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):303-309. PubMed ID: 30678454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body distribution of polysorbate-80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats.
    Ambruosi A; Yamamoto H; Kreuter J
    J Drug Target; 2005 Dec; 13(10):535-42. PubMed ID: 16390814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity and apoptotic gene expression in an in vitro model of the blood-brain barrier following exposure to poly(butylcyanoacrylate) nanoparticles.
    Hall AM; Hemmer R; Spaulding R; Wetzel HN; Curcio J; Sabel BA; Henrich-Noack P; Pixley S; Hopkins T; Boyce RL; Schultheis PJ; Haik KL
    J Drug Target; 2016 Aug; 24(7):635-44. PubMed ID: 26707984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles.
    Wohlfart S; Khalansky AS; Bernreuther C; Michaelis M; Cinatl J; Glatzel M; Kreuter J
    Int J Pharm; 2011 Aug; 415(1-2):244-51. PubMed ID: 21641983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles.
    Duan J; Mansour HM; Zhang Y; Deng X; Chen Y; Wang J; Pan Y; Zhao J
    Int J Pharm; 2012 Apr; 426(1-2):193-201. PubMed ID: 22274587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats.
    Bagad M; Khan ZA
    Int J Nanomedicine; 2015; 10():3921-35. PubMed ID: 26089668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model.
    Wang CX; Huang LS; Hou LB; Jiang L; Yan ZT; Wang YL; Chen ZL
    Brain Res; 2009 Mar; 1261():91-9. PubMed ID: 19401168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.